MXCAX
Price
$13.50
Change
-$0.21 (-1.53%)
Updated
Nov 13 closing price
Net Assets
14.97M
RNWHX
Price
$96.22
Change
-$1.24 (-1.27%)
Updated
Nov 13 closing price
Net Assets
76.61B
Interact to see
Advertisement

MXCAX vs RNWHX

Header iconMXCAX vs RNWHX Comparison
Open Charts MXCAX vs RNWHXBanner chart's image
BlackRock Emerging Markets Ex-Chn Inv A
Price$13.50
Change-$0.21 (-1.53%)
VolumeN/A
Net Assets14.97M
American Funds New World R5E
Price$96.22
Change-$1.24 (-1.27%)
VolumeN/A
Net Assets76.61B
MXCAX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
MXCAX vs. RNWHX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXCAX is a Buy and RNWHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 76.6B vs. MXCAX (15M). RNWHX pays higher dividends than MXCAX: RNWHX (0.90) vs MXCAX (0.58). MXCAX was incepted earlier than RNWHX: MXCAX (3 years) vs RNWHX (10 years). MXCAX (3.35) is less costly to investors than RNWHX (0.72). MXCAX is a more actively managed with annual turnover of: 86.00 vs. RNWHX (37.00). RNWHX has a lower initial minimum investment than MXCAX: RNWHX (250) vs MXCAX (1000). RNWHX annual gain was more profitable for investors over the last year : 20.99 vs. MXCAX (19.21).
MXCAXRNWHXMXCAX / RNWHX
Total Expense Ratio1.120.72156%
Annual Report Gross Expense Ratio3.350.72465%
Fund Existence3 years10 years-
Gain YTD27.53526.572104%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets15M76.6B0%
Annual Yield % from dividends0.580.9064%
Returns for 1 year19.2120.9992%
Returns for 3 yearsN/A48.72-
Returns for 5 yearsN/A24.39-
Returns for 10 years253.98N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPVG5.950.15
+2.59%
TRIPLEPOINT VENTURE GROWTH BDC Corp
PRO23.13N/A
N/A
Pros Holdings
MRVL89.33N/A
N/A
Marvell Technology
ITRM0.60-0.01
-1.67%
Iterum Therapeutics plc
ALKS31.41-2.41
-7.11%
Alkermes plc